Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jarno L. Kivioja
Observed names:
J KIVIOJA,
Jarno Kivioja,
Kivioja, Jarno
Institutions:
University of Zurich,
University Hospital Zurich
Observed institutions:
University of Helsinki,
University of Zurich,
Helsinki University Hospital,
University Hospital Zurich,
Institute for Molecular Medicine Finland,
HiLIFE – Elämäntieteiden Instituutti
show all 6
ORCID:
0000-0002-4046-0963
Observed ORCID:
0000-0002-4046-0963
OpenAlex ID:
A5060298368
Dasatinib and navitoclax act synergistically to target NUP98-NSD1+/FLT3-ITD+ acute myeloid leukemia
2018
·
Jarno L. Kivioja
, Angeliki Thanasopoulou
, et al.
·
Leukemia
·
66
Interleukin 8 Promoter Polymorphism Predicts the Initial Response to Bevacizumab Treatment for Exudative Age-related Macular Degeneration
2013
·
Asta Hautamäki
, Jarno Kivioja
, et al.
·
Retina
·
38
The genetic variant rs4073 A→T of the Interleukin‐8 promoter region is associated with the earlier onset of exudative age‐related macular degeneration
2015
·
Asta Hautamäki
, Sanna Seitsonen
, et al.
·
Acta Ophthalmologica
·
33
PDF
The IL-8, VEGF, and CFH Polymorphisms and Bevacizumab in Age-related Macular Degeneration
2014
·
Asta Hautamäki
, Jarno Kivioja
, et al.
·
Ophthalmology
·
19
FLT3-ITD allelic ratio and HLF expression predict FLT3 inhibitor efficacy in adult AML
2021
·
Jarno Kivioja
, Disha Malani
, et al.
·
Scientific Reports
·
17
PDF
ChimericNUP98–NSD1transcripts from the cryptic t(5;11)(q35.2;p15.4) in adult de novo acute myeloid leukemia
2017
·
Jarno L. Kivioja
, Jesus M. Lopez Martí
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
7
IAP dependency of T-cell prolymphocytic leukemia identified by high-throughput drug screening
2025
·
Marcel Fabian Pohly
, Kerstin Putzker
, et al.
·
Blood
·
3
Inferring tumor-specific cancer dependencies through integrating ex vivo drug response assays and drug-protein profiling
2022
·
Alina Batzilla
, Junyan Lu
, et al.
·
PLoS Computational Biology
·
2
PDF
The effects of interleukin‐8, VEGF and CFH polymorphisms on the long‐term response to bevacizumab therapy in exudative age‐related macular degeneration
2013
·
A HAUTAMäKI
, J KIVIOJA
, et al.
·
Acta Ophthalmologica
·
2
Lymphoma and Leukemia Cell Vulnerabilities and Resistance Identified by Compound Library Screens
2024
·
Katarzyna Tomska
, Sebastian Scheinost
, et al.
·
Methods in molecular biology
·
1
Domain-adversarial learning predicts clinically actionable drug combination synergy in leukemia patients using bulk transcriptomics data
2026
·
Jie Zhu
, Weikaixin Kong
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
Dissecting the Single Cell Landscape of Leukemic Mantle Cell Lymphoma
2023
·
Tobias Wertheimer
, Hosna Baniadam
, et al.
·
Blood
PDF
Interleukin-8 production by cells in peripheral blood is associated with age-related macular degeneration lesion activity during anti-VEGF treatment and with variants of the interleukin-8 gene
2019
·
Ilkka Immonen
, Alexandra Robciuc
, et al.
·
Investigative Ophthalmology & Visual Science
The NUP98-NSD1 fusion gene in acute myeloid leukemia
2019
·
Jarno Kivioja
·
Helda - University of Helsinki Institutional Repository
Abstract 1892: Discovery of targeted therapies for acute myeloid leukemia patients with NUP98-NSD1 and FLT3-ITD
2018
·
Jarno Kivioja
, Angeliki Thanasopoulou
, et al.
·
Cancer Research
Identification of Optimized Compound Combinations for the Treatment of NUP98-NSD1+ AML
2016
·
Jarno Kivioja
, Angeliki Thanasopoulou
, et al.
·
Blood
Identification of Novel Therapeutic Strategies for NUP98-NSD1-Positive AML By Drug Sensitivity Profiling
2014
·
Jarno Kivioja
, Mika Kontro
, et al.
·
Blood
Interleukin‐8 promoter polymorphism is associated with the initial repose to bevacizumab in AMD treatment
2013
·
I IMMONEN
, A HAUTAMÄKI
, et al.
·
Acta Ophthalmologica
Show more works
View as search
Works count:
19
Citation count:
188
H-index:
6
I10-index:
5
Year
Topic
Type